MREO Mereo Biopharma Group PLC

Fundamentals / CIK 0001719714 / USD

Mereo Biopharma Group PLC reported $500K in revenue and a net loss of $26.94M for the fiscal year ended December 31, 2025, with a -6080.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open MREO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$14.42M$7.21M$0-$41.29MFY 2022 Revenue: $0FY 2022 Net Income: -$42.22M2022FY 2023 Revenue: $10.00MFY 2023 Net Income: -$29.47M2023FY 2024 Revenue: $0FY 2024 Net Income: -$43.25M2024FY 2025 Revenue: $500KFY 2025 Net Income: -$41.88M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Revenue $500K $0 $10.00M $0
Research & Development $17.77M $20.93M $17.42M $29.46M
Operating Income -$40.11M -$47.36M -$28.42M -$54.43M
EBITDA -$39.48M -$46.78M -$27.85M -$54.24M
Interest Income $2.17M $3.04M $2.13M $840K
Interest Expense $255K $1.37M $2.88M $4.17M
Income Before Tax -$41.88M -$43.25M -$30.00M -$42.94M
Income Tax Expense $0 $0 -$532K -$718K
Net Income -$41.88M -$43.25M -$29.47M -$42.22M
Basic EPS -$0.05 -$0.06 -$0.04 -$0.07
Diluted EPS -$0.05 -$0.06 -$0.04 -$0.07
Basic Shares Outstanding 797.1M 739.6M 659.5M 603.2M
Diluted Shares Outstanding 797.1M 739.6M 659.5M 603.2M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $800K $0 -- -- $0 $500K -- $0
Research & Development $2.09M $1.81M $4.75M $4.19M $4.27M $5.37M $3.93M $8.82M
Operating Income -$6.22M -$7.03M -$8.77M -$8.39M -$10.02M -$10.50M -$11.20M -$15.28M
EBITDA -$6.06M -$6.87M -$8.60M -$7.93M -$10.16M -$10.34M -$11.06M -$15.13M
Interest Income $241K $278K $327K $421K $504K $589K $659K $881K
Interest Expense $10K $16K $20K $23K $28K $24K $180K $375K
Income Before Tax -$5.86M -$7.00M -$6.72M -$7.35M -$7.02M -$14.62M -$12.89M -$7.05M
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$5.86M -$7.00M -$6.72M -$7.35M -$7.02M -$14.62M -$12.89M -$7.05M
Basic EPS -$0.01 -$0.01 -$0.01 -- -$0.01 -$0.02 -$0.02 --
Diluted EPS -$0.01 -$0.01 -$0.01 -- -$0.01 -$0.02 -$0.02 --
Basic Shares Outstanding 804.5M 803.6M 801.8M -- 799.9M 799.4M 784.3M --
Diluted Shares Outstanding 804.5M 803.6M 801.8M -- 799.9M 799.4M 784.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $40.99M $69.80M $57.42M $68.18M
Cash & Short-Term Investments $40.99M $69.80M $57.42M $68.18M
Total Current Assets $45.02M $74.76M $63.76M $75.20M
Property, Plant & Equipment, Net $137K $257K $405K $551K
Intangible Assets $516K $643K $1.09M $0
Total Non-Current Assets $897K $1.63M $2.74M $2.22M
Total Assets $45.92M $76.39M $66.50M $77.41M
Accounts Payable $1.33M $2.44M $2.35M $3.49M
Deferred Revenue (Current) $0 -- -- --
Other Current Liabilities $741K $1.09M $1.02M $1.07M
Total Current Liabilities $4.30M $13.85M $9.49M $24.38M
Other Non-Current Liabilities $661K $565K $764K $0
Total Non-Current Liabilities $699K $1.57M $6.48M $1.64M
Total Liabilities $5.00M $15.42M $15.96M $26.01M
Total Debt (incl. Leases) $202K $894K $1.56M $2.04M
Common Stock $3.13M $3.06M $2.77M $2.48M
Retained Earnings -$501.0M -$462.9M -$419.6M -$404.6M
Accumulated Other Comp. Income -$10.82M -$18.85M -$17.48M -$21.69M
Total Stockholders' Equity $40.92M $60.97M $50.54M $51.40M
Total Equity $40.92M $60.97M $50.54M $51.40M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $26.10M $30.12M $30.10M $40.99M $48.70M $56.12M $62.48M $69.80M
Cash & Short-Term Investments $26.10M $30.12M $30.10M $40.99M $48.70M $56.12M $62.48M $69.80M
Total Current Assets $28.67M $33.40M $40.03M $45.02M $52.41M $61.42M $66.90M $74.76M
Property, Plant & Equipment, Net $24K $54K $91K $137K $174K $218K $247K $257K
Intangible Assets $129K $256K $381K $516K $643K $470K $554K $643K
Total Non-Current Assets $911K $1.31M $580K $897K $1.20M $1.21M $1.42M $1.63M
Total Assets $29.58M $34.71M $40.61M $45.92M $53.60M $62.63M $68.32M $76.39M
Accounts Payable $1.00M $1.12M $3.23M $1.33M $879K $1.14M $2.92M $2.44M
Deferred Revenue (Current) $200K -- -- $0 -- -- -- --
Other Current Liabilities $888K $1.07M $905K $741K $622K $777K $894K $1.09M
Total Current Liabilities $5.49M $5.68M $6.18M $4.30M $6.02M $7.56M $7.50M $13.85M
Other Non-Current Liabilities $370K $370K $362K $661K $652K $352K $325K $565K
Total Non-Current Liabilities $378K $385K $383K $699K $988K $897K $744K $1.57M
Total Liabilities $5.87M $6.06M $6.56M $5.00M $7.00M $8.45M $8.24M $15.42M
Total Debt (incl. Leases) $577K $1.03M -- $202K $397K $601K $747K $894K
Common Stock $3.15M $3.15M $3.15M $3.13M $3.13M $3.13M $3.13M $3.06M
Retained Earnings -$520.4M -$514.5M -$507.5M -$501.0M -$493.7M -$486.6M -$472.0M -$462.9M
Accumulated Other Comp. Income -$12.27M -$12.29M -$12.57M -$10.82M -$10.91M -$8.64M -$15.29M -$18.85M
Total Stockholders' Equity $23.71M $28.65M $34.05M $40.92M $46.60M $54.18M $60.08M $60.97M
Total Equity $23.71M $28.65M $34.05M $40.92M $46.60M $54.18M $60.08M $60.97M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$41.88M -$43.25M -$29.47M -$42.22M
Depreciation & Amortization $622K $581K $566K $181K
Stock-Based Compensation $7.60M $7.39M $4.92M $4.77M
Change in Payables -$1.38M $146K -$1.26M $617K
Operating Cash Flow -$30.97M -$32.83M -$21.13M -$48.82M
Capital Expenditure -$20K $0 $0 -$13K
Free Cash Flow -$30.99M -$32.83M -$21.13M -$48.83M
Investing Cash Flow -$20K -$699K -$419K $1.99M
Common Stock Issued $39K $47.00M $11.61M $0
Financing Cash Flow $327K $46.15M $7.97M $200K
Net Change in Cash -$30.66M $12.38M -$10.76M -$46.63M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$5.86M -$7.00M -$6.72M -$7.35M -$7.02M -$14.62M -$12.89M -$7.05M
Depreciation & Amortization $159K $165K $171K $460K -$144K $162K $144K $148K
Stock-Based Compensation $909K $1.32M $1.60M $1.54M $1.71M $2.06M $2.28M $1.51M
Change in Payables -$118K -$2.14M $1.96M $447K -$236K -$1.95M $362K $843K
Operating Cash Flow -$4.05M -$6.04M -$4.31M -$7.68M -$7.31M -$7.65M -$8.33M -$9.42M
Capital Expenditure $0 $0 $0 $0 $0 $0 -$20K $0
Free Cash Flow -$4.05M -$6.04M -$4.31M -$7.68M -$7.31M -$7.65M -$8.35M -$9.42M
Investing Cash Flow $0 $0 -$300K $0 $300K $0 -$320K $0
Financing Cash Flow $0 $0 $0 $39K $0 -$134K $422K -$40K
Net Change in Cash -$4.05M -$6.04M -$4.61M -$7.64M -$7.01M -$7.79M -$8.23M -$9.46M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -8021.4% -- -284.2% --
Net Profit Margin -8375.6% -- -294.7% --
Return on Equity (ROE) -102.4% -70.9% -58.3% -82.1%
Return on Assets (ROA) -91.2% -56.6% -44.3% -54.5%
Current Ratio 10.46x 5.40x 6.72x 3.09x
Quick Ratio 9.53x 5.04x 6.05x 2.80x
Debt to Equity 0.00x 0.01x 0.03x 0.04x
Revenue Growth (YoY) -- -100.0% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -113.6% -98.1% -104.9% -102.4% -89.2% -91.5% -78.5% -70.9%
Return on Assets (ROA) -91.1% -80.9% -87.9% -91.2% -77.6% -79.1% -69.1% -56.6%
Current Ratio 5.22x 5.88x 6.48x 10.46x 8.71x 8.13x 8.92x 5.40x
Quick Ratio 4.75x 5.31x 4.87x 9.53x 8.09x 7.43x 8.33x 5.04x
Debt to Equity 0.02x 0.04x -- 0.00x 0.01x 0.01x 0.01x 0.01x
Revenue Growth (YoY) -- -100.0% -- -- -- -- -- -100.0%
Source: SEC EDGAR CompanyFacts (CIK 0001719714) · from December 31, 2022 Data through September 30, 2026 · synced Nov 20, 2026, 05:53 UTC · Open in terminal